Trovagene Shares Indicated Higher After Hours Thurs. As Co. Issues Release Highlighting Data In SABCS 'Showing Sensitivity Of Triple Negative Breast Cancer Cell Lines To PCM-075, Synergy with Zytiga'
Paul Quintaro